GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,279.00
Bid: 1,283.00
Ask: 1,285.00
Change: -35.00 (-2.66%)
Spread: 2.00 (0.156%)
Open: 1,311.00
High: 1,314.00
Low: 1,266.00
Prev. Close: 1,314.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Thu, 22nd Oct 2020 16:01

Friday 23 October 
Essentra PLCThird Quarter Results
Barclays PLCThird Quarter Results
London Stock Exchange Group PLCThird Quarter Results
InterContinental Hotels Group PLCThird Quarter Results
Airtel Africa PLCHalf Year Results
Avation PLCFull Year Results
Monday 26 October 
THG Holdings PLCThird Quarter Results
Tuesday 27 October 
Bloomsbury Publishing PLCHalf Year Results
Plus500 LtdThird Quarter Results
St James's Place PLCThird Quarter Results
HSBC Holdings PLCThird Quarter Results (at 0400 GMT)
Dechra Pharmaceuticals PLCTrading Statement
Whitbread PLCHalf Year Results
Shoe Zone PLCTrading Statement
BP PLCThird Quarter Results
Hunting PLCTrading Statement
First Derivatives PLCHalf Year Results
Renalytix AI PLCFull Year Results
ContourGlobal Group PLCTrading Statement
Wednesday 28 October 
John Laing Group PLCTrading Statement
Ibstock PLCTrading Statement
Gem Diamonds LtdTrading Statement
Elementis PLCTrading Statement
International Biotechnology Trust PLCFull Year Results
GlaxoSmithKline PLCThird Quarter Results (at midday)
Next PLCTrading Statement
Bank of Ireland Group PLCTrading Statement
Omega Diagnostics Group PLCTrading Statement
Itaconix PLCHalf Year Results
Thursday 29 October 
Royal Dutch Shell PLCThird Quarter Results
Angle PLCHalf Year Results
Standard Chartered PLCThird Quarter Results (at 0415 GMT)
WPP PLCTrading Statement
Helios Towers PLCThird Quarter Results
Smith & Nephew PLCTrading Statement
Lloyds Banking Group PLCThird Quarter Results
Travis Perkins PLCTrading Statement
KAZ Minerals PLCThird Quarter Production
BT Group PLCHalf Year Results
International Personal Finance PLCTrading Statement
Indivior PLCThird Quarter Results
Glanbia plcThird Quarter Results
Foxtons Group PLCTrading Statement
Evraz PLCTrading Statement
Smith & Nephew PLCThird Quarter Trading Statement
Proactis Holdings PLCFull Year Results
Hilton Food Group PLCTrading Statement
Verona Pharma PLCThird Quarter Results
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
16 Feb 2022 09:16

TOP NEWS: Indivior swings to profit in 2021; mulling US listing

(Alliance News) - Indivior PLC shares jumped on Wednesday after it reported a swing to profit in 2021 and annual revenue moved closer to its eventual target of USD1 billion.

Read more
16 Feb 2022 09:00

LONDON MARKET OPEN: Geopolitical tensions calm but inflation in focus

(Alliance News) - London's FTSE 100 stock index edged cautiously higher in early dealings on Wednesday, with a seeming de-escalation by Russia of its threat to Ukraine lifting the mood, though traders were wary about a backdrop of inflationary pressures in both the UK and US.

Read more
16 Feb 2022 07:49

LONDON MARKET PRE-OPEN: Franchise Brands buys fellow AIM firm Filta

(Alliance News) - Stock prices in London are seen opening slightly higher on Wednesday, adding to strong gains on Tuesday, as tensions on the Russia-Ukraine border appear to have eased.

Read more
16 Feb 2022 07:05

Indivior considers US listing after returning to profit

(Sharecast News) - Indivior said it was considering a US listing for its shares as the drugs company swung to an annual profit and predicted strong growth for its Sublocade opioid.

Read more
9 Feb 2022 16:02

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
28 Jan 2022 16:22

UPDATE: Indivior notes robust results for treatment in fentanyl trial

UPDATE: Indivior notes robust results for treatment in fentanyl trial

Read more
28 Jan 2022 14:53

CORRECT: Indivior notes results for painkiller in fentanyl trial

CORRECT: Indivior notes results for painkiller in fentanyl trial

Read more
28 Jan 2022 09:02

Indivior's painkiller demonstrates positive interaction with fentanyl

Indivior's painkiller demonstrates positive interaction with fentanyl

Read more
28 Jan 2022 07:55

Indivior welcomes results from buprenorphine-fentanyl interaction study

(Sharecast News) - Pharmaceutical company Indivior hailed the results of a study aimed at assessing the ability of its buprenorphine asset to reduce respiratory depression and apnea associated with the synthetic opioid fentanyl.

Read more
19 Nov 2021 14:56

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

Read more
10 Nov 2021 12:28

LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data

LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data

Read more
10 Nov 2021 10:12

IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million

IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million

Read more
10 Nov 2021 08:07

Indivior slumps as Scopia Capital sells 20m shares

(Sharecast News) - Indivior was under the cosh on Wednesday after US alternative asset management firm Scopia Capital sold 20m shares in the opioid addiction treatment maker in a placing.

Read more
1 Nov 2021 09:38

LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest

LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest

Read more
28 Oct 2021 13:23

Indivior lifts 2021 revenue guidance amid strong Sublocade sales

Indivior lifts 2021 revenue guidance amid strong Sublocade sales

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.